By Gilang Cahya 
A groundbreaking study from the University of Toronto has illuminated a concerning interaction between specific dietary choices and the gut microbiome, revealing how a low-carbohydrate diet can exacerbate the DNA-damaging capabilities of certain gut microbes, thereby increasing the risk of colorectal cancer. This research, published in the esteemed journal Nature Microbiology, offers critical insights into the complex interplay of factors contributing to one of the most prevalent forms of cancer globally.
The Unveiling of a Dangerous Microbial-Dietary Alliance
For years, the scientific community has recognized colorectal cancer (CRC) as a multifactorial disease, influenced by a confluence of dietary habits, the intricate ecosystem of the gut microbiome, environmental exposures, and an individual’s genetic predisposition. However, the precise mechanisms by which these elements interact have remained an active area of investigation. The University of Toronto team, spearheaded by senior author Professor Alberto Martin of the Department of Immunology at U of T’s Temerty Faculty of Medicine, and led by postdoctoral fellow Bhupesh Thakur, embarked on a mission to dissect this relationship. Their central hypothesis posited: "Does diet influence the ability of specific bacteria to cause cancer?"
To rigorously test this question, the researchers meticulously designed an experimental model using mice. These mice were colonized with one of three specific bacterial species previously implicated in the development of colorectal cancer. Concurrently, the mice were subjected to one of three distinct dietary regimens: a standard, balanced diet; a low-carbohydrate diet; or a Western-style diet, characterized by high levels of fat and sugar.
The findings from this comprehensive study were stark and significant. It was only in the presence of a specific strain of Escherichia coli (E. coli) bacteria, coupled with a diet severely restricted in carbohydrates and soluble fiber, that the researchers observed a pronounced acceleration in the development of polyps in the colon. These polyps, often referred to as adenomas, are recognized as precancerous lesions and are considered a critical precursor to colorectal cancer.
The Critical Role of Colibactin and Gut Barrier Integrity
The study’s pivotal discovery centered on a particular strain of E. coli known to produce colibactin, a potent genotoxin – a substance that damages DNA. When this colibactin-producing E. coli was present in mice on a low-carbohydrate diet, it triggered a cascade of events detrimental to the colonic epithelium.
The researchers meticulously documented how a diet deficient in both carbohydrates and soluble fiber led to an inflammatory state within the gut. This inflammation, in turn, profoundly altered the composition and balance of the resident microbial community. This dysbiotic environment proved exceptionally conducive to the proliferation of the colibactin-producing E. coli.
Further investigation revealed another critical factor: the compromised integrity of the gut lining. Mice fed a low-carb diet exhibited a significantly thinner mucus layer separating the gut microbes from the colon epithelial cells. This mucus layer normally serves as a vital physical barrier, preventing direct contact between bacteria and the delicate cells lining the colon. With this protective shield weakened, the genotoxic colibactin produced by E. coli could more readily penetrate and inflict damage on the colon cells. This genetic damage is a fundamental driver of tumor initiation and progression.
The study also highlighted a particularly concerning synergistic effect in mice with pre-existing genetic mutations in DNA mismatch repair (MMR) pathways. These pathways are the body’s natural defense mechanisms for correcting errors and damage in DNA. When these repair systems are compromised, the cells are far less capable of fixing the DNA lesions caused by colibactin, leading to a dramatically amplified risk of cancer development. This finding is particularly relevant given that defects in DNA mismatch repair are frequently observed in human colorectal cancers.
Implications for Human Health and Cancer Prevention
While the current study was conducted in a murine model, both Dr. Thakur and Professor Martin underscored the critical need for further research to validate these findings in human populations. Nevertheless, they expressed considerable optimism regarding the potential translational applications of their work in the realm of cancer prevention strategies.
Colorectal cancer stands as the fourth most commonly diagnosed cancer worldwide, and its incidence remains a significant public health concern. In Canada, for instance, an estimated 15% of colorectal tumors exhibit mutations in mismatch repair genes. Furthermore, these genetic alterations are the hallmark of Lynch syndrome, an inherited condition that dramatically elevates an individual’s lifetime risk of developing several types of cancer, including colorectal cancer.
Professor Martin articulated a compelling line of inquiry stemming from their research: "Can we identify which Lynch syndrome patients harbor these colibactin-producing microbes?" He elaborated that for individuals identified as carrying these specific bacteria, the study’s findings suggest that altering their dietary habits – specifically by avoiding low-carbohydrate diets – or potentially undergoing targeted antibiotic treatments to eradicate the colibactin-producing bacteria could serve as potent risk-reduction strategies.
Adding another layer of complexity and potential therapeutic avenues, Professor Martin noted that certain probiotic strains, such as E. coli Nissle, which is commonly found in over-the-counter probiotics, also produce colibactin. His lab is actively investigating the long-term safety implications of using such probiotics for individuals with Lynch syndrome or those adhering to low-carbohydrate diets.
The Protective Power of Fiber: A Promising Avenue
A particularly encouraging outcome from the study was the observed effect of soluble fiber supplementation. Dr. Thakur reported that when soluble fiber was added to the low-carbohydrate diet, it significantly mitigated the detrimental effects of the diet. This intervention led to reduced levels of the cancer-promoting E. coli, less DNA damage, and a lower incidence of tumor formation in the mice.
"We supplemented fibre and saw that it reduced the effects of the low-carb diet," Dr. Thakur stated. "Now we are trying to find out which fibre sources are more beneficial, and which are less beneficial." This ongoing research aims to pinpoint specific types of dietary fiber that can offer the greatest protective benefits against the adverse effects of a low-carb, low-fiber diet.
To further explore these promising findings, Dr. Thakur and Professor Martin are collaborating with Heather Armstrong, a researcher at the University of Alberta. Their joint efforts will focus on investigating whether supplementation with inulin, a type of soluble fiber, can effectively reduce the prevalence of colibactin-producing E. coli and improve gut health in individuals at high risk for colorectal cancer, such as those with inflammatory bowel disease.
A Call for Dietary Awareness and Further Research
The implications of this research extend beyond specific patient populations and touch upon broader dietary trends. Professor Martin cautioned, "Our study highlights the potential dangers associated with long-term use of a low-carb, low-fibre diet, which is a common weight-reducing diet." The widespread adoption of such restrictive diets, without a full understanding of their potential downstream consequences on gut health and cancer risk, warrants careful consideration.
While acknowledging that more extensive research is imperative, the researchers expressed a strong hope that their findings will contribute to a greater public awareness of the intricate relationship between diet, the gut microbiome, and cancer. This burgeoning field of research underscores the profound impact of our dietary choices on the microbial communities within us and, consequently, on our long-term health trajectory. The University of Toronto’s work provides a crucial piece of the puzzle, guiding future investigations towards more personalized and effective strategies for colorectal cancer prevention and management. The journey from laboratory discovery to clinical application is often a long one, but this study represents a significant leap forward in understanding a complex and critical health challenge.
